Cyclophosphamide and pemphigus vulgaris.
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D001797:Blood Protein Electrophoresis; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use*; D048909:Diabetes Complications; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D008297:Male; D008875:Middle Aged; D009135:Muscular Diseases / Q000139:chemically induced; D010024:Osteoporosis / Q000150:complications; D010392:Pemphigus / Q000150:complications / Q000188:drug therapy*; D011241:Prednisone / Q000627:therapeutic use; D012075:Remission, Spontaneous
D000305:Adrenal Cortex Hormones; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D003520:Cyclophosphamide; D011241:Prednisone